A BetterLife Pharma’s Post

⌛️🧠 The Challenge: Ethics & Psychedelics in Psychiatry When looking at the psychedelic therapy process, some burning questions come to mind: ·      What is informed consent? ·      Does supportive touch have a role in therapy? ·      Is clinician psychedelic drugs experience mandatory? The end goal is patient harm prevention before harm reduction. Pundits in psychiatry are now calling for guidelines that can protect the patient in its journey. Further reading can be found in the APA post below. Addressing these and other questions about the ethical challenges of psychedelic treatment is paramount. Taking this major step brings clarity, peace of mind, and implicit trust in the process so patient outcomes can be transformative. #mentalhealth #biotech #psychedelicmedicine #brainhealth #psychiatry $BETR: CSE $BETRF: OTCQB Psychiatric News Psychology Today Psychedelic Alpha World Health Organization American Psychiatric Association American Psychological Association Institute of Psychiatry, Psychology & Neuroscience

To view or add a comment, sign in

Explore topics